JP7840505B2 - 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物 - Google Patents

変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物

Info

Publication number
JP7840505B2
JP7840505B2 JP2025568955A JP2025568955A JP7840505B2 JP 7840505 B2 JP7840505 B2 JP 7840505B2 JP 2025568955 A JP2025568955 A JP 2025568955A JP 2025568955 A JP2025568955 A JP 2025568955A JP 7840505 B2 JP7840505 B2 JP 7840505B2
Authority
JP
Japan
Prior art keywords
galnac
osteoarthritis
expression
rheumatoid arthritis
chondrocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2025568955A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025169865A5 (https=
JPWO2025169865A1 (https=
Inventor
司 松原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPWO2025169865A1 publication Critical patent/JPWO2025169865A1/ja
Publication of JPWO2025169865A5 publication Critical patent/JPWO2025169865A5/ja
Application granted granted Critical
Publication of JP7840505B2 publication Critical patent/JP7840505B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2025568955A 2024-02-05 2025-02-03 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物 Active JP7840505B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2024015445 2024-02-05
JP2024015445 2024-02-05
PCT/JP2025/003340 WO2025169865A1 (ja) 2024-02-05 2025-02-03 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物

Publications (3)

Publication Number Publication Date
JPWO2025169865A1 JPWO2025169865A1 (https=) 2025-08-14
JPWO2025169865A5 JPWO2025169865A5 (https=) 2026-01-28
JP7840505B2 true JP7840505B2 (ja) 2026-04-03

Family

ID=96699915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025568955A Active JP7840505B2 (ja) 2024-02-05 2025-02-03 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物

Country Status (2)

Country Link
JP (1) JP7840505B2 (https=)
WO (1) WO2025169865A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008078588A1 (ja) 2006-12-25 2008-07-03 National University Corporation Tokyo Medical And Dental University 関節軟骨の変性を治療又は予防するための医薬及び方法
JP2012512177A (ja) 2008-12-16 2012-05-31 カオフシウン メディカル ユニヴァーシティー 早期変形性関節症の治療
JP2021084867A (ja) 2019-11-27 2021-06-03 学校法人慶應義塾 変形性関節症の予防薬及び治療薬

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008078588A1 (ja) 2006-12-25 2008-07-03 National University Corporation Tokyo Medical And Dental University 関節軟骨の変性を治療又は予防するための医薬及び方法
JP2012512177A (ja) 2008-12-16 2012-05-31 カオフシウン メディカル ユニヴァーシティー 早期変形性関節症の治療
JP2021084867A (ja) 2019-11-27 2021-06-03 学校法人慶應義塾 変形性関節症の予防薬及び治療薬

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAYASHI, S. et al.，A genome-wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis，Biomedical Reports，2021年，Vol. 14, No. 3，31，doi:10.3892/br.2021.1407, ISSN:2049-9434
積山 賢 ほか，N-アセチルガラクトサミン転移酵素12(GalNAc-T12)の軟骨細胞への影響の検討，第66回 日本リウマチ学会総会・学術集会 プログラム・抄録集，2022年03月07日，p. 341

Also Published As

Publication number Publication date
WO2025169865A1 (ja) 2025-08-14
JPWO2025169865A1 (https=) 2025-08-14

Similar Documents

Publication Publication Date Title
US11180810B2 (en) Methods for detecting hepatic fibrosis and responsiveness to therapy
WO2020181235A1 (en) Il-10 variant molecules and methods of treating inflammatory disease and oncology
EP3464608A1 (en) Therapeutic recombinant klotho proteins and compositions and methods involving the same
CN113286604B (zh) 治疗炎症性疾病的蛋白质
US8173360B2 (en) Cell death inhibitor
EP3615694B1 (en) Il-8, il-6, il-1b and tet2 and dnmt3a in atherosclerosis
CN104582727B (zh) 利用Slit-Robo系统用于预防或治疗骨折或骨质疏松症的组合物
US20170119861A1 (en) Methods and compositions for the treatment of amyloidosis
JP4754532B2 (ja) ヒアルロン酸オリゴ糖を有効成分とする治療剤
JP7840505B2 (ja) 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物
US20210008164A1 (en) Erythropoietin for Gastrointestinal Dysfunction
EP3182980B1 (en) Treatment of glycosylation deficiency diseases
CN106267235B (zh) miR-451作为调节血糖的靶标的用途
US20160346350A1 (en) Compositions and methods for treating or preventing a bone condition
JP5346216B2 (ja) 治療
CN110179968B (zh) 核仁素在制备用于改善糖代谢紊乱的药物中的应用
US20250188473A1 (en) Methods Of Treating Liver Diseases With Phosphodiesterase 3B (PDE3B) Inhibitors
KR20250025642A (ko) 만성 염증성 탈수초성 다발신경병증과 같은 신경계의 질환 또는 장애의 치료에 사용하기 위한 알파1-항트립신
US20200222505A1 (en) Methods of delaying and preventing acute myeloid leukemia relapse
WO2023034993A1 (en) Compositions and methods for diagnosing, detecting and treating eosinophil-related diseases
CN1494588A (zh) 蛋白质组氨酸磷酸酶的用途
US20250302891A1 (en) Microbiome biomarkers for irritable bowel disease (ibd)
US20250360186A1 (en) Dosage regimen for interleukin-22 derivatives
JP2005531640A (ja) 組換えタンパク質におけるａｄｐ−リボース−アルギニンに対する機能的置換体としてのトリプトファン
EP4488284A1 (en) Prorenin receptor peptide, conjugate, and pharmaceutical composition

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251125

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20251125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260114

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260318

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260324

R150 Certificate of patent or registration of utility model

Ref document number: 7840505

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150